MAPT and Alzheimer disease: As reported in the next subsections, the Aβ, tau and Aβ∙tau molecular associates of AD pathogenesis were further investigated in terms of overrepresented biological mechanisms, cellular types associated with brain-wide functional affectations and pharmacological agents with potential therapeutic benefit (Figure 1C).